Department of Organic Chemistry, Faculty of Pharmaceutical Chemistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, 1417614411, Iran.
Bioorg Chem. 2019 Oct;91:103164. doi: 10.1016/j.bioorg.2019.103164. Epub 2019 Jul 29.
Multi-Target approach is particularly promising way to drug discovery against Alzheimer's disease. In the present study, we synthesized a series of compounds comprising the carbazole backbone linked to the benzyl piperazine, benzyl piperidine, pyridine, quinoline, or isoquinoline moiety through an aliphatic linker and evaluated as cholinesterase inhibitors. The synthesized compounds showed IC values of 0.11-36.5 µM and 0.02-98.6 µM against acetyl- and butyrylcholinesterase (AChE and BuChE), respectively. The ligand-protein docking simulations and kinetic studies revealed that compound 3s could bind effectively to the peripheral anionic binding site (PAS) and anionic site of the enzyme with mixed-type inhibition. Compound 3s was the most potent compound against AChE and BuChE and showed acceptable inhibition potency for self- and AChE-induced Aβ aggregation. Moreover, compound 3s could significantly protect PC12 cells against HO-induced toxicity. The results suggested that the compounds 3s could be considered as a promising multi-functional agent for further drug discovery development against Alzheimer's disease.
多靶点方法是治疗阿尔茨海默病的一种很有前途的药物发现方法。在本研究中,我们合成了一系列化合物,这些化合物包含咔唑骨架,通过脂肪族连接子与苄基哌嗪、苄基哌啶、吡啶、喹啉或异喹啉部分相连,并评估了它们作为胆碱酯酶抑制剂的活性。合成的化合物对乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BuChE)的 IC 值分别为 0.11-36.5 μM 和 0.02-98.6 μM。配体-蛋白对接模拟和动力学研究表明,化合物 3s 可以有效地与酶的外周阴离子结合位点(PAS)和阴离子结合位点结合,具有混合抑制作用。化合物 3s 对 AChE 和 BuChE 的抑制活性最强,对自身和 AChE 诱导的 Aβ聚集也具有可接受的抑制活性。此外,化合物 3s 可显著保护 PC12 细胞免受 HO 诱导的毒性。结果表明,化合物 3s 可被视为一种有前途的多功能药物,可进一步开发用于治疗阿尔茨海默病。